Johnson Controls Awarded Seven Year Agreement With Novartis
12 October 2000
Johnson Controls Awarded Seven Year Agreement With NovartisATLANTA, Oct. 11 Johnson Controls, Inc. has announced an agreement with Novartis for the delivery of integrated facility management and infrastructure services. Subject to due diligence, the contracts are expected to be signed by the end of November 2000 and are valued at approximately $115 million (200 Million Swiss Francs) per year for seven years. Johnson Controls will support four Novartis sites across their Basel, Switzerland headquarters and will standardize facility management service delivery across ten million square feet of facilities that includes manufacturing, research and development and administrative operations in support of Novartis' healthcare business. Technical maintenance services and maintenance process automation will be delivered across all manufacturing equipment and scientific testing equipment. Johnson Controls will also provide infrastructure support services covering the full spectrum of facility management from mailroom and reprographics to security, fire services and emergency service management. Key drivers in the agreement included Johnson Controls experience in providing integrated facility management support to pharmaceutical industry leaders and its expertise in supporting portfolios that must operate within the parameters of the Food and Drug Administration accreditation process. Johnson Controls has committed to deliver guaranteed savings to Novartis and plans to retain every Novartis employee impacted by the agreement. To this effect, 1,000 Novartis staff currently based in Basel will be transferred to employment with Johnson Controls. "We are looking forward to delivering the knowledge and best practices we've gained through our work within the pharmaceutical industry," states Robert Netolicka, President of Johnson Controls Integrated Facility Management. "Partnering with Novartis creates an opportunity to share our expertise and help Novartis exceed their business goals." "Johnson Controls possesses the necessary competencies and has a corporate culture that matches our ideas about performance and personnel policies," comments Hans Kindler, member of the Novartis Executive Committee.